Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed Floats Human Factors Design As Industry Cost-Containment Strategy

This article was originally published in The Gray Sheet

Executive Summary

Device firms can contribute to the health care cost-containment aims of the Obama administration by making devices less prone to human error, industry reps say

You may also be interested in...



New Human Factors Device Design Standard Due Out In April

Device makers and FDA staff are hoping a new standard due out next month from the Association for the Advancement of Medical Instrumentation will help firms design devices - from infusion pumps to cardiac monitors - that are less prone to human error

New Human Factors Device Design Standard Due Out In April

Device makers and FDA staff are hoping a new standard due out next month from the Association for the Advancement of Medical Instrumentation will help firms design devices - from infusion pumps to cardiac monitors - that are less prone to human error

Devices Account For 6.2% Of Health Expenditures, AdvaMed Study Finds

As congressional reformers look for ways to cut health care costs, AdvaMed aims to raise awareness that medical devices and diagnostics represent only a single-digit share of national health care expenditures

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027514

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel